Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Abdallah S. Geara"'
Autor:
Jordana B. Cohen, MD, MSCE, Abdallah S. Geara, MD, Jonathan J. Hogan, MD, Raymond R. Townsend, MD
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 2, Pp 238-251 (2019)
Cancer patients and survivors of cancer have a greater burden of cardiovascular disease compared with the general population. Much of the elevated cardiovascular risk in these individuals is likely attributable to hypertension, because individuals wi
Externí odkaz:
https://doaj.org/article/946d1e48748f4beba5e3d91df46c24d8
Publikováno v:
Journal of Onco-Nephrology. 7:6-10
Bevacizumab is an anti-angiogenic monoclonal antibody against vascular endothelial growth factor (VEGF) and has multiple indications with known renal adverse effects, notably proteinuria, and acute kidney injury (AKI). There is insufficient knowledge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e8bd605da4be1704a9ba84e6d44b086
https://doi.org/10.1177/23993693221131584
https://doi.org/10.1177/23993693221131584
Publikováno v:
BMJ case reports. 14(8)
Tyrosine kinase inhibitors (TKI) are anticancer agents widely used for a variety of malignancies including gastrointestinal stromal tumours (GIST). Although generally well-tolerated, TKIs have been associated with a number of adverse events including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef1cd4611ab1f16dbae5994b3b7eacb
https://pubmed.ncbi.nlm.nih.gov/34380680
https://pubmed.ncbi.nlm.nih.gov/34380680
Publikováno v:
American Journal of Kidney Diseases. 78:A12-A15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f921c4867847180cab0779a3f48db89
https://doi.org/10.1053/j.ajkd.2021.03.031
https://doi.org/10.1053/j.ajkd.2021.03.031
Autor:
Maylene Kefeng Qiu, Rachel Hilburg, Robert A Burger, Abdallah S. Geara, Jonathan J. Hogan, Matthew Palmer, Elaine Y Chiang
Publikováno v:
Clinical Nephrology. 96:51-59
Background Bevacizumab is a recombinant monoclonal antibody against the vascular endothelial growth factor A (VEGF-A) ligand that is used in the management of various solid malignancies. The adverse effect profiles of angiogenesis inhibitors, such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d4ec7fadb6eb86db194a1089769e21
https://doi.org/10.5414/cn110443
https://doi.org/10.5414/cn110443
Publikováno v:
Glomerular Diseases. 1:40-43
Introduction: B-cell depletion has been shown to be an effective strategy for the majority of patients with membranous nephropathy (MN), and in PLA2R-positive MN, immunologic remission (improvement or elimination of measurable serum anti-PLA2R antibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d54b28a568aa43be9ad902b5022ba84f
https://doi.org/10.1159/000515087
https://doi.org/10.1159/000515087
Publikováno v:
Vox Sanguinis. 116:793-797
BACKGROUND AND OBJECTIVES Deferasirox is an oral chelator approved for iron overload, which has a potential side effect of renal Fanconi syndrome, with proximal tubular dysfunction and tubular acidosis. Monitoring of renal function is recommended, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6611dd940adbe137e8b67c525b74ae85
https://doi.org/10.1111/vox.13064
https://doi.org/10.1111/vox.13064
Autor:
Ryan Spiardi, Abdallah S. Geara
Publikováno v:
Hypercalcemia ISBN: 9783030931810
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9481e80f4e7f0ad704ed063a8c55fe80
https://doi.org/10.1007/978-3-030-93182-7_1
https://doi.org/10.1007/978-3-030-93182-7_1
Publikováno v:
Clinical Nephrology. 97:193-194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22df16691a6279d445984bea40898a17
https://doi.org/10.5414/cn110689
https://doi.org/10.5414/cn110689
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 2, Pp 238-251 (2019)
Cancer patients and survivors of cancer have a greater burden of cardiovascular disease compared with the general population. Much of the elevated cardiovascular risk in these individuals is likely attributable to hypertension, because individuals wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9610ef5435ba50ed805bb048686b990
https://doi.org/10.1016/j.jaccao.2019.11.009
https://doi.org/10.1016/j.jaccao.2019.11.009